Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion

by Narendra V. Sankpal, Taylor C. Brown, Timothy P. Fleming, John M. Herndon, Anusha A. Amaravati, Allison N. Loynd, William E. Gillanders
Published 2021-05-01

Cancer Genome Sequencing and Its Implications for Personalized Cancer Vaccines

by William E. Gillanders, Ted H. Hansen, Beatriz M. Carreno, Timothy P. Fleming, John M. Herndon, Xiuli Zhang, Matthew J.C. Ellis, Elaine R. Mardis, Lijin Li, Peter Goedegebuure
Published 2011-11-01

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation

by Lijin Li, Xiuli Zhang, Xiaoli Wang, Samuel W. Kim, John M. Herndon, Michelle K. Becker-Hapak, Beatriz M. Carreno, Nancy B. Myers, Mark A. Sturmoski, Michael D. McLellan, Christopher A. Miller, Tanner M. Johanns, Benjamin R. Tan, Gavin P. Dunn, Timothy P. Fleming, Ted H. Hansen, S. Peter Goedegebuure, William E. Gillanders
Published 2021-04-01